Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Garcia

Showing results (411-420 of 455) with videos related to

Pageof 46
Sort By:
The New England Journal of Medicine|May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American Heart Association|July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCaroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology|January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyMichael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
JACC. Cardiovascular Imaging|June 30, 2023
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-AmyloXabier Arana-Achaga, Cristina Goena-Vives, Iñaki Villanueva-Benito, et al.
JMIR Research Protocols|October 12, 2022
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled TrialPablo Garcia-Manau, Manel Mendoza, Erika Bonacina, et al.
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation. Heart Failure|September 23, 2020
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> GeneMohammed Majid Akhtar, Massimiliano Lorenzini, Marcos Cicerchia, et al.
Brain Communications|December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspectiveCharis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteinsRaquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Pageof 46

Showing results (411-420 of 455) with videos related to

Sort By:
Pageof 46
The New England Journal of Medicine|May 13, 2024
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Michael E Nassif, et al.
Journal of the American Heart Association|July 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCMCaroline J Coats, Ahmad Masri, Michael E Nassif, et al.
Journal of the American College of Cardiology|January 6, 2026
Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic CardiomyopathyMichael E Nassif, Pablo Garcia-Pavia, Ahmad Masri, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
JACC. Cardiovascular Imaging|June 30, 2023
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-AmyloXabier Arana-Achaga, Cristina Goena-Vives, Iñaki Villanueva-Benito, et al.
JMIR Research Protocols|October 12, 2022
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled TrialPablo Garcia-Manau, Manel Mendoza, Erika Bonacina, et al.
Circulation. Genomic and Precision Medicine|August 18, 2023
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of <i>RBM20</i> VariantsDouglas E Cannie, Alexandros Protonotarios, Athanasios Bakalakos, et al.
Circulation. Heart Failure|September 23, 2020
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> GeneMohammed Majid Akhtar, Massimiliano Lorenzini, Marcos Cicerchia, et al.
Brain Communications|December 13, 2021
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspectiveCharis Wong, Maria Stavrou, Elizabeth Elliott, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteinsRaquel Puerta, Pablo Garcia-Gonzalez, Itziar de Rojas, et al.
Pageof 46